For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

In a gold-standard model of obesity, treatment with ARD-201 resulted in approximately 19% body weight reduction after 30 days of treatment.ARD-201 was also associated with attenuated weight regain ...

Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard ...

(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical complications ...

Promising medication given before surgery could improve surgical outcomes and reduce healthcare burdens associated with obesity.

Fat jabs could soon be available over the counter at pharmacies without the need for a GP, according to rppeorts. Fat jabs ...